Tanimoto Sarina 的 Form 4 申報
ARS Pharmaceuticals, Inc.（SPRY），2024/8/15 申報
- 申報編號
- 0001415889-24-021363
- 申報時間
- 2024/8/15
- 交易日
- 2024/8/13
- 申報延遲
- 2 天
- 10b5-1 計畫
- 有勾選
這份申報列了 4 筆非衍生性交易。公開市場賣出合計 $124.8 萬。交易後 2 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Tanimoto SarinaCIK 0001951291 | 高階主管（醫療長）、持股 10% 以上大股東 |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2024/8/13 | Common Stock | S賣出處分 | −14,599 | $11.78F2 | −$171,976.22 | 1,481,895 | 間接 | 重複申報 |
| 2024/8/13 | Common Stock | S賣出處分 | −35,401 | $12.76F4 | −$451,716.76 | 1,446,494 | 間接 | 重複申報 |
| 2024/8/13 | Common Stock | S賣出處分 | −14,637 | $11.77F5 | −$172,277.49 | 1,583,862 | 間接 | 重複申報 |
| 2024/8/13 | Common Stock | S賣出處分 | −35,363 | $12.77F7 | −$451,585.51 | 1,548,499 | 間接 | 重複申報 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F2
The weighted average sale price for the transaction report was $11.7753,and the range of prices were between $11.31 and $12.22. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares old at each separate price will be provided.
表 I 有 1 筆交易的價格引用這則附註。
- F4
The weighted average sale price for the transaction reported was $12.7646, and the range of prices were between $12.24 and $13.085. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
表 I 有 1 筆交易的價格引用這則附註。
- F5
The weighted average sale price for the transaction reported was $11.7734, and the range of prices were between $11.335 and $12.215. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
表 I 有 1 筆交易的價格引用這則附註。
- F7
The weighted average sale price for the transaction reported was $12.7659, and the range of prices were between $12.35 and $13.095. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
表 I 有 1 筆交易的價格引用這則附註。